Otros idiomas Jiuzhitang Co., Ltd.

Acciones

000989

CNE000001394

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 07/06/2024			Varia. Cinco días.	Varia. 1 de enero.
6,9 ^CNY	+2,07 %		+3,45 %	-31,82 %

24/04	Jiuzhitang Co. Ltd. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI
18/03	Jiuzhitang Co. (SZSE:000989) anuncia una recompra de acciones por valor de 100 millones de CNY.	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Jiuzhitang Co., Ltd. Approves Final Cash Dividend for the Year 2023	20/05
Jiuzhitang Co., Ltd.(XSEC:000989) dropped from S&P Global BMI Index	08/05
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	25/04
Jiuzhitang Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24/04
Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.	02/04
Jiuzhitang Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	18/03
Jiuzhitang Co., Ltd. authorizes a Buyback Plan.	18/03
Jiuzhitang's Unit to Launch Clinical Trials Into Human Bone Marrow Stem Cell Injection; Shares Drop 3%	02/11
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	08/08/23
Jiuzhitang Unit to Hold Clinical Trial Into Stem Cell Treatment	12/06/23
Jiuzhitang Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023	30/05/23
Jiuzhitang Co., Ltd. Approves Cash Dividend for the Year 2022	25/05/23
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend for 2022	04/05/23
Jiuzhitang Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Jiuzhitang Co., Ltd. Appoints Bo Jinfeng as Non-Independent Director	11/01/23
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Jiuzhitang Cleared to Launch Clinical Trial of Deep Vein Thrombosis Drug	22/09/22
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22
Jiuzhitang Co., Ltd. Appoints Wang Yonghui as a Non-Independent Director	17/08/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Jiuzhitang Co., Ltd.

Acciones

000989

CNE000001394

Otros idiomas

Filtros